KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $9.8 million.

  • CRISPR Therapeutics AG's Prepaid Assets rose 1850.47% to $9.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.8 million, marking a year-over-year increase of 1850.47%. This contributed to the annual value of $9.8 million for FY2025, which is 1850.47% up from last year.
  • As of Q4 2025, CRISPR Therapeutics AG's Prepaid Assets stood at $9.8 million, which was up 1850.47% from $13.4 million recorded in Q3 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Prepaid Assets ranged from a high of $41.7 million in Q2 2022 and a low of $8.2 million during Q3 2024
  • Moreover, its 5-year median value for Prepaid Assets was $21.1 million (2023), whereas its average is $22.9 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 7993.5% in 2021, then plummeted by 6184.89% in 2023.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Prepaid Assets stood at $38.1 million in 2021, then dropped by 0.97% to $37.7 million in 2022, then crashed by 61.85% to $14.4 million in 2023, then crashed by 42.26% to $8.3 million in 2024, then increased by 18.5% to $9.8 million in 2025.
  • Its Prepaid Assets stands at $9.8 million for Q4 2025, versus $13.4 million for Q3 2025 and $12.4 million for Q2 2025.